Clinical Trial Update: Indoxyl Sulfate Induces Leukocyte-endothelial Interactions Through Up-regulation of ICAM-1 in Acute Kidney Injury

View source ↗

Summary

A clinical trial update describing how indoxyl sulfate may promote leukocyte-endothelial interactions by upregulating ICAM-1 in acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Indoxyl sulfate (Indoxyl sulfate)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Renal Function Disorder | Status: UNKNOWN